Work

619P Pelareorep + atezolizumab and chemotherapy in third-line (3L) metastatic colorectal cancer (mCRC) patients: Interim results from the GOBLET study

Year: 2023

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.09.1810

Authors: G. Ungerechts, D. Arnold, E. Goekkurt, A. Stein, J. Chater, U.M. Martens, H. Loghmani, M. Coffey, R. Trauger, T.C. Heineman

Institutions: National Center for Tumor Diseases, Asklepios Klinik Altona, Asklepios, Klinikum Chemnitz, SLK-Kliniken Heilbronn, Oncolytics Biotech (Canada)

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4387825398

FWCI: 0.243

Cites:

Cited by: 2

Related to: 10